Search clinical trials for: Lerociclib Letrozole or Fulvestrant
Total 120 results
-
Haihe Biopharma Co., Ltd.Not yet recruiting
-
Inge Marie SvaneWithdrawn
-
iOMEDICO AGNovartis PharmaceuticalsCompletedBreast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast CancerGermany
-
Fuzhou General HospitalNot yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive TumorChina
-
German Breast GroupPfizer; AMS Advanced Medical Services GmbHRecruitingMetastatic Breast CancerGermany
-
Borstkanker Onderzoek GroepActive, not recruitingBreast Neoplasm FemaleNetherlands
-
Fudan UniversityUnknown
-
MedSIRCompletedMetastatic Breast CancerSpain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7United States
-
Fondazione Sandro PitiglianiCompleted
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Hormone Receptor Positive TumorSweden
-
SanofiActive, not recruitingBreast Cancer MetastaticKorea, Republic of, Belgium, Taiwan, China, France, United States, Argentina, Australia, Brazil, Canada, Czechia, Greece, Israel, Italy, Japan, Latvia, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey, Ukraine
-
Yazd Research & Clinical Center for InfertilityCompleted
-
PfizerRecruitingBreast Cancer | Head and Neck CancerKorea, Republic of, Mexico, Ukraine, United States
-
Celcuity, Inc.Completed
-
Institut Claudius RegaudCompletedHormono-depending Adjuvant Breast CancerFrance
-
Ruth O'ReganUniversity of Rochester; Puma Biotechnology, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast CancerUnited States
-
Centre Oscar LambretCompleted
-
Shayna Showalter, MDActive, not recruitingBreast Cancer FemaleUnited States
-
The Netherlands Cancer InstituteTerminated
-
Avenzo Therapeutics, Inc.Recruiting
-
wang shusenRecruiting
-
Palleos Healthcare GmbHPfizer; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP; AGO-TraFo; AGO-B; Deutsche...Terminated
-
Oana DanciuNovartis PharmaceuticalsRecruitingHER2-negative Breast Cancer | Locoregional Recurrence | Hormone Receptor-positive Breast CancerUnited States
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; German Breast GroupCompletedBreast CancerSpain, Germany
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany
-
AstraZenecaNot yet recruiting
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Taiwan, Canada, Germany, Argentina, Israel, Korea, Republic of, Denmark, France, India, Chile, Netherlands, Singapore, Japan, Mexico
-
German Breast GroupCompletedBreast Cancer MetastaticGermany
-
Instituto Nacional de Cancer, BrazilCancer Research UK Cambridge InstituteUnknown
-
Eastern Virginia Medical SchoolWatson PharmaceuticalsCompletedPolycystic Ovary SyndromeUnited States
-
MedSIREli Lilly and CompanyActive, not recruitingBreast Cancer MetastaticItaly, Spain, Portugal
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
Massachusetts General HospitalGenentech, Inc.Active, not recruiting
-
Tianjin Medical University Cancer Institute and...RecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
SCRI Development Innovations, LLCNovartisCompleted
-
Emory UniversityNovartisTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Heilongjiang University of Chinese MedicineUnknownPolycystic Ovary SyndromeChina
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina
-
Genentech, Inc.Active, not recruitingBreast Cancer | Solid TumorUnited States, France, Spain, United Kingdom, Canada
-
Washington University School of MedicinePfizerCompletedBreast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of BreastUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
Medical College of WisconsinWithdrawnAdvanced Breast Cancer | Solid TumorUnited States
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerUnited States
-
University of PittsburghTerminatedNon-small Cell Lung Cancer | Postmenopausal WomenUnited States
-
PfizerRecruitingBreast Neoplasms | Prostate Cancer | Adenocarcinoma of Lung | Solid Tumors | Liposarcoma | CRCChina, United States, United Kingdom, Mexico, Czechia, Japan, Slovakia, Argentina
-
MedSIRNovartisActive, not recruiting
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma | Solid CancersUnited States, Spain, France, Canada